Thursday, October 3, 2019

Compounding Pharmacists Respond to John Oliver's Comments About Lack of Regulation 2019-10-02 06:31:00 Aislinn Antrim, Assistant Editor

https://www.pharmacytimes.com/news/john-oliver-said-compounding-is-underregulated-some-disagree

FOUR PEOPLE CHARGED, FIFTH PLEADS GUILTY, IN $4.5 MILLION HEALTH CARE FRAUD CONSPIRACY TARGETING STATE HEALTH BENEFITS PROGRAMS October 3, 2019, 11:53 am | in

https://www.insidernj.com/press-release/four-people-charged-fifth-pleads-guilty-4-5-million-health-care-fraud-conspiracy-targeting-state-health-benefits-programs/

FDA now says impurity level in Zantac and other antacids is too high by Eric Palmer | Oct 2, 2019 11:54am

https://www.fiercepharma.com/manufacturing/fda-now-says-impurity-level-zantac-and-other-antacids-too-high?mkt_tok=eyJpIjoiT1RKbVlURmxNekEyWldabCIsInQiOiIrWVd1OFJNUCtvaXl3R1pkS1lWcUR4d3dnUVlvS0k3SFF6WnFJR0Z2SURKYStmeTVCcTRFb2FxYlwvR2RRSlUwanE1RkxcL0J2d2VhQktZM3F1R0w2UkNiU0w2Y3I4VWE1ODZEdm1XemtJQkRyXC91alVqdGZDODlYMGFiaU8xZEFRNSJ9&mrkid=765989

CDC: Outbreak of Lung Injury Associated with E-Cigarette Use, or Vaping

https://www.cdc.gov/tobacco/basic_information/e-cigarettes/severe-lung-disease.html

Vaping-related lung injuries resemble chemical burns, study finds By ANDREW JOSEPH @DrewQJosephOCTOBER 2, 2019

https://www.statnews.com/2019/10/02/vaping-related-lung-injuries-resemble-chemical-burns-study-finds/

Wednesday, October 2, 2019

TRUMP TO NOMINATE HAHN AS FDA COMMISSIONER BY STEVE USDIN, WASHINGTON EDITOR | OCT 1, 2019 | 5:01 PM CDT

https://www.biocentury.com/bc-extra/politics-policy/2019-10-01/trump-nominate-hahn-fda-commissioner

FDA in Brief: FDA awards grant for information-sharing system and research of interstate distribution of compounded drugs, as part of agency’s effort to help address risks with poor-quality compounded drugs

Today, the U.S. Food and Drug Administration is announcing that it has awarded a cooperative agreement grant to the National Association of Boards of Pharmacy (NABP) to establish an information-sharing system for drug compounding activities that are primarily overseen by states. The roughly three-year pilot project undertaken through this grant will work to improve the information available to state regulators and the FDA about state-licensed entities, primarily pharmacies, that engage in drug compounding and distribute compounded drugs interstate. The overall goal is to help provide more ...

Tuesday, October 1, 2019